Home › Ovarian Cancer › Ohio › Parma
Ovarian Cancer clinical trials in Parma, OH
4 studies for Ovarian Cancer are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- UH Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- University Hospitals Parma Medical Center, Parma
- UH Seidman Cancer Center at Saint John Medical Center, Westlake · 11 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- University Hospitals Parma Medical Center, Parma
- UH Seidman Cancer Center at Saint John Medical Center, Westlake · 11 mi away
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RecruitingPhase 3
- St. John Medical Center, Westlake · 11 mi away
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Parma
- Ulcerative Colitis10 studies
- Crohn's Disease8 studies
- Steatotic Liver Disease7 studies
- Psoriatic Arthritis6 studies
- Lung Cancer5 studies
- Major Depressive Disorder5 studies
- Schizophrenia5 studies
- Endometrial Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Inflammatory Bowel Disease4 studies
- Alzheimer's Disease4 studies
- Psychotic Disorders4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.